Radium 223 Blog
Video the radium-223 and metastatic prostate cancer
fred saad, md, professor and chief of urology, director of genitourinary oncology at the university of montreal hospital centers, discusses radium-223 dichlo. oliver sartor, md, board professor, cancer research, tulane university, discusses a trial that would study provenge (sipuleucel-t) in combination with radium-223 as a potential treatment option . oliver sartor, md, medical director, tulane cancer center, describes the patients that were included in the phase iii alsympca trial that examined radium-223 (alpharadin), an experimental .